
Sign up to save your podcasts
Or


Recent headlines about arsenic found in popular candies have sparked widespread concern among parents, manufacturers, and legal professionals alike. But what do these findings actually mean — scientifically and legally?
In this episode of Legal Owl, host John Brocas is joined by Dr. Alex LeBeau, PhD — toxicologist, exposure scientist, and expert witness — to unpack the data behind Florida’s recent arsenic testing results and the public response that followed.
Rather than fueling fear, this conversation focuses on context: how toxicology data should be interpreted, the difference between detection and risk, and why methodology, thresholds, and exposure pathways matter when evaluating potential harm. Dr. LeBeau explains why the presence of a substance alone does not automatically indicate danger — and how misinterpretation of scientific data can lead to regulatory confusion, public anxiety, and increased litigation risk.
This episode also explores the legal implications for manufacturers and counsel, including:
Important context:
This episode does not claim that candy is unsafe, nor does it assert wrongdoing by regulators or manufacturers. Instead, it examines how scientific findings are communicated, how risk is assessed in toxicology, and how incomplete or decontextualized data can create legal and reputational consequences.
For lawyers, expert witnesses, compliance professionals, and manufacturers navigating product safety, regulatory scrutiny, or emerging exposure claims, this episode offers a grounded, thoughtful framework for understanding what the data really says — and what it doesn’t.
Links referenced in this episode:
By Jock BrocasRecent headlines about arsenic found in popular candies have sparked widespread concern among parents, manufacturers, and legal professionals alike. But what do these findings actually mean — scientifically and legally?
In this episode of Legal Owl, host John Brocas is joined by Dr. Alex LeBeau, PhD — toxicologist, exposure scientist, and expert witness — to unpack the data behind Florida’s recent arsenic testing results and the public response that followed.
Rather than fueling fear, this conversation focuses on context: how toxicology data should be interpreted, the difference between detection and risk, and why methodology, thresholds, and exposure pathways matter when evaluating potential harm. Dr. LeBeau explains why the presence of a substance alone does not automatically indicate danger — and how misinterpretation of scientific data can lead to regulatory confusion, public anxiety, and increased litigation risk.
This episode also explores the legal implications for manufacturers and counsel, including:
Important context:
This episode does not claim that candy is unsafe, nor does it assert wrongdoing by regulators or manufacturers. Instead, it examines how scientific findings are communicated, how risk is assessed in toxicology, and how incomplete or decontextualized data can create legal and reputational consequences.
For lawyers, expert witnesses, compliance professionals, and manufacturers navigating product safety, regulatory scrutiny, or emerging exposure claims, this episode offers a grounded, thoughtful framework for understanding what the data really says — and what it doesn’t.
Links referenced in this episode: